ELOXX PHARMACEUTICALS, INC. (ELOX) Shareholders’ equity 2010–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$11.9MFY2025 · since FY2010: $8.0M → -$11.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.9M | +51.1% |
| FY2024 | -$24.3M | -7.7% |
| FY2023 | -$22.6M | — |
| FY2014 | $27.5M | +626.1% |
| FY2013 | $3.8M | +9.6% |
| FY2012 | $3.5M | — |
| FY2010 | $8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice